Hamele C, Luo Z, Leonard R, Spurrier M, Burke K, Webb S
J Virol. 2024; 98(10):e0116624.
PMID: 39324791
PMC: 11495035.
DOI: 10.1128/jvi.01166-24.
Zhang X, Skarlupka A, Shi H, Ross T
Hum Vaccin Immunother. 2024; 20(1):2403175.
PMID: 39291424
PMC: 11657087.
DOI: 10.1080/21645515.2024.2403175.
Zhang X, Ross T
Expert Rev Vaccines. 2024; 23(1):474-484.
PMID: 38632930
PMC: 11157429.
DOI: 10.1080/14760584.2024.2343689.
Song W, Wan M, She J, Zhao S, Liu D, Chang H
Viruses. 2024; 16(1).
PMID: 38257777
PMC: 10819419.
DOI: 10.3390/v16010077.
Besavilla D, Reusch L, Enriquez J, Schon K, Angeletti D
Front Immunol. 2023; 14:1243164.
PMID: 37711622
PMC: 10499173.
DOI: 10.3389/fimmu.2023.1243164.
Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza.
Werninghaus I, Hinke D, Fossum E, Bogen B, Braathen R
Mol Ther. 2023; 31(7):2188-2205.
PMID: 36926694
PMC: 10362400.
DOI: 10.1016/j.ymthe.2023.03.012.
Universal protection against influenza viruses by multi-subtype neuraminidase and M2 ectodomain virus-like particle.
Kim K, Li Z, Bhatnagar N, Subbiah J, Park B, Shin C
PLoS Pathog. 2022; 18(8):e1010755.
PMID: 36006890
PMC: 9409530.
DOI: 10.1371/journal.ppat.1010755.
Immune Escape Adaptive Mutations in Hemagglutinin Are Responsible for the Antigenic Drift of Eurasian Avian-Like H1N1 Swine Influenza Viruses.
Xu C, Zhang N, Yang Y, Liang W, Zhang Y, Wang J
J Virol. 2022; 96(16):e0097122.
PMID: 35916512
PMC: 9400474.
DOI: 10.1128/jvi.00971-22.
A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model.
Pliasas V, Menne Z, Aida V, Yin J, Naskou M, Neasham P
Front Immunol. 2022; 13:915364.
PMID: 35874791
PMC: 9300842.
DOI: 10.3389/fimmu.2022.915364.
Characterization of PSOP26 as an ookinete surface antigen with improved transmission-blocking activity when fused with PSOP25.
Wang P, Jiang X, Bai J, Yang F, Yu X, Wu Y
Parasit Vectors. 2022; 15(1):175.
PMID: 35606790
PMC: 9125894.
DOI: 10.1186/s13071-022-05294-8.
Influenza Neuraminidase Characteristics and Potential as a Vaccine Target.
Creytens S, Pascha M, Ballegeer M, Saelens X, de Haan C
Front Immunol. 2021; 12:786617.
PMID: 34868073
PMC: 8635103.
DOI: 10.3389/fimmu.2021.786617.
A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model.
Strohmeier S, Amanat F, Zhu X, McMahon M, Deming M, Pasetti M
mBio. 2021; 12(6):e0224121.
PMID: 34809451
PMC: 8609353.
DOI: 10.1128/mBio.02241-21.
Influenza Vaccines: Successes and Continuing Challenges.
Becker T, Elbahesh H, Reperant L, Rimmelzwaan G, Osterhaus A
J Infect Dis. 2021; 224(12 Suppl 2):S405-S419.
PMID: 34590139
PMC: 8482026.
DOI: 10.1093/infdis/jiab269.
Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.
Menne Z, Pliasas V, Compans R, Glover S, Kyriakis C, Skountzou I
Virology. 2021; 562:197-208.
PMID: 34375782
PMC: 8479372.
DOI: 10.1016/j.virol.2021.08.001.
Targeting Antigens for Universal Influenza Vaccine Development.
Nguyen Q, Choi Y
Viruses. 2021; 13(6).
PMID: 34073996
PMC: 8225176.
DOI: 10.3390/v13060973.
Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses.
Kerstetter L, Buckley S, Bliss C, Coughlan L
Front Immunol. 2021; 11:607333.
PMID: 33633727
PMC: 7901974.
DOI: 10.3389/fimmu.2020.607333.
Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine.
Giurgea L, Morens D, Taubenberger J, Memoli M
Vaccines (Basel). 2020; 8(3).
PMID: 32718039
PMC: 7564061.
DOI: 10.3390/vaccines8030409.
The Quest for a Truly Universal Influenza Vaccine.
Jang Y, Seong B
Front Cell Infect Microbiol. 2019; 9:344.
PMID: 31649895
PMC: 6795694.
DOI: 10.3389/fcimb.2019.00344.
Structural restrictions for influenza neuraminidase activity promote adaptation and diversification.
Wang H, Dou D, Ostbye H, Revol R, Daniels R
Nat Microbiol. 2019; 4(12):2565-2577.
PMID: 31451775
DOI: 10.1038/s41564-019-0537-z.
Protective Antibodies Against Influenza Proteins.
Padilla-Quirarte H, Lopez-Guerrero D, Gutierrez-Xicotencatl L, Esquivel-Guadarrama F
Front Immunol. 2019; 10:1677.
PMID: 31379866
PMC: 6657620.
DOI: 10.3389/fimmu.2019.01677.